JBIO: Aerovate Therapeutics, Inc. Price Target Chart

Corporate company logo of Aerovate (JBIO)

Aerovate Therapeutics Inc (JBIO) is overcoming a crisis triggered by the failure of its lead drug, necessitating a strategic pivot to mitigate stagnation risks. The implementation of AI and automated testbeds, which accelerate formula analysis, is providing support. This chart illustrates that the asset's market value is 49.19. The business relies on developing inhalation therapies for pulmonary hypertension, which serve as a cash cow by generating multi-year revenue through lifelong treatment.

Aerovate Therapeutics Inc (JBIO): Price Target Chart from 04/30/2025 to 11/17/2026

Analytical breakdowns for Aerovate Therapeutics, Inc. (JBIO)

- market capitalization information:
General company analysis:JBIO Aerovate Therapeutics Inc
Flagship merchandise of Aerovate Therapeutics

The consensus forecast represents a weighted average target price of an asset, aggregating the expectations of leading investment houses to determine the growth potential or the risk of overvaluation of the security. By analyzing the market's aggregate consensus target, an investor can assess how effectively the logistics optimization and contractor diversification of Aerovate Therapeutics Inc (JBIO) are reflected in the fundamental value of the shares, balancing high returns against the probability of a deep capital drawdown.

Competitors of Aerovate Therapeutics Inc

Analyst Consensus Forecast argenx N.V. (ARGX)|Price Target Chart BioNTech SE BNTX|Abivax Corp - Price Target Chart|ADMA - Price Target Chart|Analyst Target Range Protagonist (PTGX)|IMVT (Immunovant, Inc.) - Consensus Target|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Analyst Consensus Forecast|Price Target Chart Grifols|Adaptive Biotechnologies Corp - Forecast Levels Chart|Analyst Consensus Forecast CLDX|AUPH (Aurinia Pharmaceuticals) - Fair Value Consensus|Analyst Consensus Forecast BCRX (biocryst.com)|Analyst Consensus Forecast Vera Therapeutics Inc VERA|DNTH - Price Target Chart|Fair Value Consensus PHVS (Pharvaris Pharma)|AbCellera Corp (ABCL) - Price Target Chart|Consensus Target Tourmaline Bio, Inc.|PGEN (precigen.com) - Analyst Consensus Forecast|Analyst Consensus Forecast Pharming|Consensus Target NKTR (Nektar)|Analyst Median Target Upstream Pharma|Analyst Consensus Forecast ZBIO (zenasbio.com)|Analyst Median Target immunome.com (IMNM)|GOSS - Price Target Chart|KalVista Pharma (KALV) - Consensus Target|Septerna Pharma (SEPN) - Price Target Chart|Consensus Target Pieris Pharmaceuticals|Consensus Target SVRA|Analyst Consensus Forecast rigel.com|Price Target Chart AnaptysBio Corp (ANAB)|Astria Therapeutics, Inc. - Broker Consensus Forecast|Analyst Consensus Forecast ENGN (engene.com)|RAPT Therapeutics Inc. (RAPT) - Average Forecast Price|Aclaris Therapeutics, Inc - Analyst Consensus Forecast|KYTX - Analyst Consensus Forecast|TLSA: Analyst Consensus Forecast|Cabaletta Bio (CABA) - Analyst Consensus Forecast|Price Target Chart Ventyx Biosciences|Average Forecast Price Theratechnologies, Inc THTX|Price Target Chart Avalo Therapeutics, Inc (AVTX)|eledon.com - Broker Consensus Forecast|agenusbio.com - Consensus Target|Climb Bio, Inc. - Price Target Chart|Zura Bio - Analyst Consensus Forecast|Forecast Levels Chart ATYR|ADAG: Analyst Consensus Forecast|IMA (ImageneBio) - Price Target Chart|Price Target Chart Shattuck Therapeutics|EQ: Fair Value Consensus|Analyst Consensus Forecast CNTB|Analyst Median Target Immunic Therapeutics|Atara Bio - Consensus Target|Analyst Median Target inflarx.de (IFRX)|XFOR (X4 Pharmaceuticals Inc.) - Average Forecast Price|ACET - Analyst Consensus Forecast|CELU: Analyst Consensus Forecast|INMB - Analyst Median Target|Price Target Chart Barinthus Biotherapeutics PLC|Kezar Life Sciences (KZR) - Analyst Median Target|Analyst Consensus Forecast SABS|Analyst Consensus Forecast Akari Therapeutics plc (AKTX)|Analyst Consensus Forecast ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc. - Price Target Chart|GOVX: Consensus Target|EDSA (Edesa Biotech, Inc.) - Broker Consensus Forecast|iBio (IBIO) - Price Target Chart|CARM: Analyst Forecast Prices|XTLB (XTL Bio) - Analyst Consensus Forecast|Bolt Biotherapeutics (BOLT) - Analyst Median Target|Analyst Consensus Forecast HCWB|Analyst Median Target Aptevo Therapeutics Inc.|Price Target Chart AIM ImmunoTech AIM|ADTX - Consensus Target|GRI: Consensus Target|XRTX (XORTX) - Broker Consensus Forecast|HIND: Analyst Consensus Forecast|REVB - Analyst Median Target|Price Target Chart Indaptus|Scinai Immunotherapeutics Ltd. (SCNI) - Analyst Median Target|Price Target Chart CalciMedica Inc (CALI)|AFMD - Average Forecast Price|Price Target Chart Allakos Inc. ALLK|Fair Value Consensus HOOK|IGM Biosciences - Analyst Consensus Forecast|Fair Value Consensus ITOS (iTeos Therapeutics Inc)|OCEA: Analyst Consensus Forecast|Broker Consensus Forecast TCBP|THRD (Third Harmonic Bio Inc) - Analyst Consensus Forecast